Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: role in oxidative stress.
Introduction
Neuregulin1 (Nrg1) is a signalling protein belonging to the Epidermal Growth Factor (EGF) gene family that mediates various cellular processes, such as cell growth, survival, migration, in different cell types, through the ErbB receptors. Nrg1/ErbB system is essential for a correct cardiac development, as demonstrated by the lethal effects of its depletion at embryonic stages [1, 2] . Furthermore, it is now clear that also in adult heart this signalling plays a critical role in the normal function as well as in ischemia or other pathological conditions [3, 4] . In the NRG1 gene, alternative splicing gives rise to different isoforms and, in adult heart, cardiac microvascular endothelial cells (EC) express soluble Nrg1 isoforms (type I and type II), both alpha and beta variants [5] , which stimulate cell survival and growth [6] , glucose up-take [5] , protein synthesis and "hypertrophic" gene expression [7] . Nrg1 mediated the cross-talk between EC and cardiomyocytes that express ErbB receptors [8] , and the deletion of Nrg1 from EC increases the infarct area and the number of TUNEL positive cells after ischemia and reperfusion (I/R) injury [9] .
ErbB receptors belong to the tyrosine kinase receptor family, and work as dimers. Among the four ErbB receptors only ErbB3 and ErbB4 can bind directly Nrg1; ErbB3 signals only as heterodimer and ErbB2 is the preferred partner for heterodimerization, while ErbB4 can form both homo and heterodimers. Initially only ErbB1, ErbB2 and ErbB4 were thought to be expressed in adult heart. In 2011, Camprecios and colleagues demonstrated that mouse postnatal cardiomyocytes express a functional ErbB3 protein that is localized mainly in the outer areas of T-Tubules with a non-uniform distribution [10] . Although a methylation of ERBB3 gene has been observed in human dilated cardiomyopathy [11] , the function of ErbB3 in adult heart remains still unknown. Recently, it has been demonstrated that a E3 ligase known as "neuregulin receptor degradation protein-1" (Nrdp1), which targets specifically ErbB3 [12] , is upregulated after I/R injury. The mouse model over-expressing Nrdp1 is characterized by higher infarct size, increased TUNEL-positive nuclei and inflammatory cells [13] . It was postulated that Nrdp1 is a pro-apoptotic signal in heart during I/R injury and that its action is mediated principally by the degradation of ErbB3.
For its pro-survival effect Nrg1 has been proposed as a potential drug for heart failure treatment. Several pre-clinical studies in rat or mouse models of heart failure and two clinical trial [14, 15] demonstrated that intravenous administration of recombinant soluble Nrg1 improved cardiac contractility and relaxation [16, 17] , left ventricular remodelling [18] ,
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It has not yet been investigated whether Nrg1/ErbB system is modulated by existing therapeutic strategies aimed to protect the heart against ischemia and reperfusion injury. One of the most interesting cardioprotective strategy is the so-called "Postconditioning" (PostC, i.e., brief cycles of ischemia/reperfusion carried out after a sustained ischemia) [20] [21] [22] [23] , which can reduce the infarct size in animal models [24, 25] and humans [26] [27] [28] . The cardioprotective mechanisms activated by PostC comprise the activation of multiple pathways, including the so-called RISK (Akt/ERK/GSK3-β) and SAFE (JNK/STAT3) pathways [29] [30] [31] . Since these pathways are downstream of the Nrg1/ErbB system [29, 30, 31] , which in PostC context is scarcely investigated, we studied how this system is influenced by I/R and the PostC procedures.
We analysed the early changes in Nrg1/ErbB system following ischemia/reperfusion injury in isolated rat heart, with or without the PostC treatment. Moreover, we investigated in a cardiomyocyte cell line whether the ErbB3 receptor plays a role in oxidative stress.
Overall results suggest that this receptor can be involved in the myocardial response to ischemia and reperfusion challenge. In particular, we confirmed that ErbB3 is expressed in rat adult heart and we demonstrated, for the first time, that its expression is upregulated in postischemic heart, suggesting that ErbB3 protein might play a role in PostC and oxidative injury limitation. 

Langendorff's heart model
Methods for Langendorff's isolated rat hearts were similar to those previously described [32, 33] . In brief, each animal was weighed and treated with heparin (800 U/100 g b.w., i.m.).
Then, 10 min afterwards, animal was sacrificed, the heart was rapidly excised and placed in ice-cold buffer solution and weighed. Isolated hearts were retrogradely perfused at constant flow (9 ± 1 ml/min/g) with oxygenated Krebs-Henseleit buffer (127 mM NaCl, 17.7 mM NaHCO3, 5.1 mM KCl, 1.5 mM CaCl2, 1.26 mM MgCl2, 11 mM D-glucose) (Sigma-Aldrich, St.
Louis, MO, USA) gassed with 95% O2 and 5% CO2, paced at 280 bpm and kept in a temperature-controlled chamber (37°C).
Experimental Protocols
After 20 min of stabilization, hearts were randomly divided in three groups: (1) Control group (Sham), hearts were subjected to 150 min perfusion only; (2) I/R group, hearts underwent 30 min of global ischemia and then a period of 120 min full reperfusion; (3) PostC group, after 30 min ischemia, hearts underwent a PostC protocol (5 cycles of 10 sec reperfusion and 10 sec of global ischemia) then a period of 120 min full reperfusion [24] .
Myocardial Injury
Infarct size
Immediately after reperfusion each heart was quickly removed from the perfusion apparatus and the apical part of the heart was collected and frozen for biomolecular analysis. The remaining basal part of the left ventricle was dissected into 2-3 mm circumferential slices.
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Lactate dehydrogenase analysis
Since in isolated rat hearts PostC is known to reduce the production of lactate dehydrogenase (LDH) during reperfusion, the release of this enzyme was tested. Samples of coronary effluent (2 ml) were collected with a catheter inserted into the right ventricle via the pulmonary artery. Samples were collected immediately before ischemia during reperfusion. Thereafter samples were collected every 20 min until the end of reperfusion. LDH release was measured as previously described and data are expressed as cumulative values for the entire reperfusion period [24, 32] .
RNA isolation and cDNA preparation
Total RNA was extracted from half apex from each heart, previously dissociated by pestles, The reaction was performed for 10 min at 25 °C, 90 min at 50 °C, 15 min at 70 °C. The obtained cDNA was diluted 10 folds with water and stored at -20 °C.
Quantitative real-time PCR (qRT-PCR) analysis
Quantitative real-time PCR analysis was performed in a 7300 real-time PCR system (Applied Biosystems For the oxidative stress we treated H9C2, H9C2-ErbB3 and H9C2-mock cells with hydrogen peroxide solution (H202, H1009, SIGMA), used for 2 hours, in a range of concentration 100 µM-300 µM to obtain 40-50% of cell mortality. Untreated H9c2 were compared to H9c2 exposed to 50 ng/ml Nrg1-β1 (recombinant human NRG1-β1/HRG1-β1 extracellular domain, # 377-HB-050, R&D Systems, Minneapolis, MN).
A pre-treatment of the cells with 50 ng/ml Nrg1 for 2 h was also performed, followed by the oxidative stress with hydrogen peroxide solution. Cell survival rate was obtained using the thiazolyl blue tetrazolium bromide (MTT, M2128, SIGMA) assay, following producer's instruction. Cell survival rate of each cell group were analysed separately. For each independent experiment, data for each condition were calibrated to the control ("no stress") sample.
For Bax and Bcl-2 analysis, cells were seeded on 60 mm dish and exposed to oxidative stress as described above. After 3h of reperfusion (cells in medium with 2% of fetal bovin serum) protein were extracted with boiling Laemmli buffer. Primary antibodies used are: anti-Bax 1 ). After 30 min ischemia and 2 hours reperfusion, the mRNA levels of ErbB1 and ErbB2 did not differ significantly from the Sham (Fig. 1a ), regardless of PostC procedure. Similar results were obtained for the four ErbB4 isoforms (Fig. 1b) . Conversely, ErbB3 mRNA (Fig. 1a) displayed a 2.8 fold increase after I/R (p<0.05compared to the Sham) and a 2.6 fold increase after PostC (P=0.081 with respect to Sham).
Nrg1 transcription was also investigated, discriminating between the two isoforms alpha and beta. qRT-PCR analysis did not reveal changes in transcription among samples, as shown in Fig. 1c .
The analysis was then shifted from the mRNA level to the protein level, to investigate ErbB3 protein expression. The western blot analysis confirmed the expression of ErbB3 protein in rat adult heart ( Fig. 2a) . A quantitative analysis revealed an appreciable downregulation (p=0.063) of ErbB3 in I/R samples compared to the PostC (Fig. 2a ), in partial contrast with mRNA analysis. We then analysed a marker of protein translation, namely phospho-S6 protein (p-S6), a subunit of ribosome S40 (when S6 subunit is phosphorylated the translation is permitted). The analysis revealed that I/R samples have a lower level of p-S6 when compared to PostC (p=0.012, Fig. 2a ). Yet in PostC sample p-S6 was upregulated respect to the Sham (p<0.05, Fig. 2a ). Furthermore, we checked the expression of Nrdp1, the E3 ligase targeting ErbB3, and we found that in I/R group the Nrdp1 mRNA level is significantly higher compared to Sham (2.6± 0.9 fold increase, p=<0.05) but not in PostC group (Fig. 2b) . Nrdp1 protein levels were analyzed in a western blot assay: the protein is and ErbB4 (data not shown), they were transiently transfected for the expression of ErbB3 receptor, and were subjected to oxidative stress with hydrogen peroxide. In non-transfected cells the administration of Nrg1, before or simultaneously to the oxidative stress, had no effect on cell survival rate in a MTT test (Fig 3a) . The expression of ErbB3 was confirmed with a western blot, together with ErbB2 protein constitutively expressed by H9c2 (Fig. 3b ). Results
show that ErbB3-expressing cells tolerate oxidative stress better than control cells (H9c2mock) in each treatment evaluated. Nevertheless, the addition of Nrg1 to the medium did not increase cell survival rate in H9c2-ErbB3 and H9c2-mock cells (Fig. 3c) . We analysed the Bax/Bcl-2 ratio as an indicator of cell apoptosis. We found that in H9c2-ErbB3 cells the ratio, after oxidative stress, remains lower respect to H9c2-mock cells (Fig. 3d,e ). Moreover, the analysis of JC-1 fluorescent probe confirms that ErbB3 expression in H9c2 cells significantly limits the reduction of mitochondrial membrane potential with respect to H9c2-mock cells in all treatment performed (Fig 3f) .
Discussion
To determine whether ErbB receptors and Nrg1 are early affected by the ischemiareperfusion injury and PostC treatment, we analyzed mRNA and protein expression levels in samples collected from the rat heart injured by global I/R, in a Langendorff's model which, like all experimental paradigms, has advantages and disadvantages [37] . For instance, Langendorff's model allows to perform a global ischemia, subjecting the heart to a homogeneous stress insult, and to remove unwanted blood cells, protein and mRNA from the myocardium, thus allowing to perform a "clean" molecular analysis.
The expression analysis of ErbB receptors reveals an upregulation of ErbB3 mRNA after ischemic injury, while the expression of the other ErbB receptors is not perturbed. As far as we know, this is the first time that ErbB3 mRNA is shown to be regulated in post-ischemic heart. Since no statistic differences in ErbB3 expression were detectable between PostC and I/R samples, it is likely that this upregulation is mainly a direct early response to the I/R, not modifiable with PostC. Yet, PostC can positively affect the translation machinery, thus preserving ErbB3 protein synthesis.
It is known that ErbB2 and ErbB4 mRNA expression is reduced in human and rat heart after heart failure [3, 38, 39] . This was observed also in diabetic animals, showing cardiac dysfunctions [40] . It was proposed that the downregulation of ErbB2 and ErbB4 is a late characteristic of the chronic heart injury. Here we focused on the early changes occurring in gene expression after I/R challenge and PostC, suggesting that in the early-phase ErbB2 and ErbB4 are not regulated at transcriptional level.
ErbB3 mRNA is upregulated after I/R, while for ErbB3 protein only a tendency to downregulation in I/R group, but not in PostC samples, can be observed. This tendency is considered the effect of a balance between protein synthesis and degradation in the protected and non-protected heart. Our data regarding the level of P-S6 provide evidences that after I/R injury the cell damage affects also the translation machinery, with a reduction of protein
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It has been shown that mouse model overexpressing Nrdp1 exhibit a downregulation of ErbB3 protein but only after I/R injury [13] . Nrdp1 degrades ErbB3 and our data suggest that this mechanism is perturbed after PostC treatment. In fact, we detected lower amount of Nrdp1 protein in PostC samples respect to I/R samples. Directly or indirectly mechanical PostC can influence ErbB3 protein levels, so we can assume that ErbB3 signalling pathway can be part of the protective signalling recruited by PostC treatment. It is well known that PostC activates PI3K-Akt pathway [42] . Actually, ErbB3 receptor has six docking sites for the binding of PI3K-p85 and this can result in a higher activation of PI3K-Akt pathway respect to the other ErbB receptors [43, 44] . Zhang et al., observed in mice after coronary artery ligation that the phosphorylation of ErbB3 increases respect to the sham, meanwhile ErbB3 protein is unchanged [13] . At the time point analyzed we did not observe ErbB3 or AKT phosphorylation (data not shown), however we cannot rule out that it occurs in an earlier or later time.
In literature, data about Nrg1 expression in damaged heart are conflicting: in diabetic animals Nrg1 protein is reduced [40] , while in human failing myocardium Nrg1 expression increases [39] . In animal models of heart failure, after an initial upregulation, Nrg1 level decreases, coincidently with the development of ventricular hypertrophy and pump failure [45] .
In I/R scenario, cardioprotection by Nrg1 induced pharmacological conditioning has been described: in vivo Nrg1 pre-conditioning activates the protective PI3K/Akt pathway [46] .
Similarly, post-conditioning with Nrg1, in both in situ and in isolated murine hearts, exerted a cardioprotective effect via PI3K/Akt pathway [47] . The same authors evidenced that Nrg1 activates this pathway only after I/R injury but not in sham samples. Therefore, we can argue that these protective effects involved also ErbB3 post-ischemic upregulation. [48] . The pivotal role of ErbB receptors in cell survival after hypoxia/reoxygenation has also been observed using zinc pyrithione, which restores the basal zinc levels during I/R and prevents apoptosis by activating PI3K/Akt [49] .
Since in our data ErbB3 mRNA is upregulated after I/R, we can argue that the cellular response to Nrg1 and its beneficial effects are mediated by ErbB2-ErbB3 heterodimer [50] . [32] , our data suggest that oxidative stress activated ErbB3 signaling and that this receptor is involved in the protective adaptation to cardiac oxidative stress.
It is becoming more and more clear that Nrg1/ErbB system is a potential target for therapy in heart failure as highlighted by the promising results obtained in the clinical studies with Nrg1 administration [14, 15] . However, the intrinsic mechanism of Nrg1 action is not completely understood; a better knowledge of Nrg1 and ErbB regulation in ischemia/reperfusion injury is now required to ameliorate the cure and increase the heart performance after acute myocardial infarction.
Conclusions
This is the first study emphasizing ErbB3 mRNA upregulation in the heart subjected to 
